<DOC>
	<DOCNO>NCT01733043</DOCNO>
	<brief_summary>The objective study determine effect dexmedetomidine infusion Apnea / Hypopnea Index ( AHI ) individual previously document obstructive sleep apnea . We hypothesize dexmedetomidine infusion may reduce AHI patient obstructive sleep apnea ( OSA ) .</brief_summary>
	<brief_title>Sedative Effects Obstructive Sleep Apnea</brief_title>
	<detailed_description />
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>All individual previously undergone diagnostic polysomnography Sleep Lab document significant OSA , undergone change likely alter severity condition since time diagnostic sleep study ( loss weight ; surgical therapy OSA ; removal tonsil ; discontinuation medication likely affect arousal respiratory function , etc . ) eligible participate . Subjects identify complete outpatient sleep study record previous sleep study perform Duke Sleep Laboratory . After obtain informed consent , subject screen history physical examination , 12lead electrocardiogram , comprehensive metabolic profile . Exclusion criterion include history illicit drug alcohol dependence , impaired hepatic ( aspartate aminotransferase alanine aminotransferase &gt; 2x upper limit normal range ) renal function ( receive dialysis serum creatinine &gt; 1.5 mg/dL ) , highgrade ( &gt; 1st degree ) heart block , know allergy dexmedetomidine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>